Great West Life Assurance CO Tg Therapeutics, Inc. Transaction History

Great West Life Assurance CO

  • $58 Billion
  • Q4 2024

A detailed history of Great West Life Assurance CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 128,637 shares of TGTX stock, worth $5.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128,637
Previous 132,368 2.82%
Holding current value
$5.13 Million
Previous $3.1 Million 25.01%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$21.31 - $35.09 $79,507 - $130,920
-3,731 Reduced 2.82%
128,637 $3.87 Million
Q3 2024

Nov 13, 2024
BUY
$17.21 - $25.28 $2.03 Million - $2.98 Million
117,894 Added 814.52%
132,368 $3.1 Million
Q2 2024

Aug 12, 2024
BUY
$13.32 - $19.19 $26,679 - $38,437
2,003 Added 16.06%
14,474 $258,000
Q3 2023

Nov 14, 2023
BUY
$8.36 - $26.5 $57,683 - $182,850
6,900 Added 123.86%
12,471 $104,000
Q2 2023

Aug 10, 2023
SELL
$15.48 - $35.0 $17,198 - $38,885
-1,111 Reduced 16.63%
5,571 $139,000
Q3 2022

Nov 01, 2022
BUY
$4.57 - $8.4 $30,536 - $56,128
6,682 New
6,682 $40,000
Q2 2021

Aug 11, 2021
BUY
$32.5 - $48.96 $1,430 - $2,154
44 Added 0.66%
6,682 $259,000
Q1 2021

May 17, 2021
SELL
$41.61 - $54.3 $29,168 - $38,064
-701 Reduced 9.55%
6,638 $317,000
Q3 2020

Nov 17, 2020
SELL
$18.49 - $27.24 $3.73 Million - $5.49 Million
-201,666 Reduced 96.49%
7,339 $196,000
Q3 2020

Nov 13, 2020
BUY
$18.49 - $27.24 $3.77 Million - $5.55 Million
203,709 Added 3846.47%
209,005 $5.59 Million
Q2 2020

Aug 17, 2020
SELL
$8.9 - $21.84 $836 - $2,052
-94 Reduced 1.74%
5,296 $103,000
Q4 2019

Feb 11, 2020
BUY
$5.1 - $11.2 $27,488 - $60,367
5,390 New
5,390 $59,000
Q3 2019

Oct 25, 2019
SELL
$5.38 - $8.99 $26,926 - $44,994
-5,005 Closed
0 $0
Q2 2019

Jul 31, 2019
SELL
$6.27 - $8.65 $1,924 - $2,655
-307 Reduced 5.78%
5,005 $0
Q2 2018

Aug 10, 2018
BUY
$12.5 - $15.0 $66,400 - $79,680
5,312 New
5,312 $70,000
Q1 2018

May 10, 2018
SELL
$8.7 - $16.8 $94,299 - $182,095
-10,839 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$10.0 - $12.7 $108,390 - $137,655
10,839
10,839 $127,000

Others Institutions Holding TGTX

# of Institutions
373
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.79B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email